Biohackers

Nadeem Kassam

FOUNDER | CATALYST

Nadeem is a wellness champion, founder of Basis Science, and the visionary behind BioBeats and our concentration on heart data. He was recently inducted into StartupHealth's inaugural class of Healthcare Transformers. He has spent the better half of the last decade running Zynik Capital, which focuses on start-ups and organizations with high growth potential. He holds a B.A. from Babson College with a focus on entrepreneurship.

Davide Morelli

CO-FOUNDER | VP ENGINEERING

Davide Morelli leads the BioBeats team. A specialist in the intersection between Artificial Intelligence and music, he previously ran a successful distributed software consultancy (Parser) for ten years. He is also an active composer graduating from the Conservatorio "Pietro Mascagni" Livorno, and his PhD focuses on energy models for algorithms that illuminate correlations.

Dr. David Plans

CO-FOUNDER | VP PRODUCT

David leads the BioBeats product vision. His PhD presented evolutionary computation techniques to imitate and question human creativity. He helped build the first European merger for Open Source startups, and is currently helping the UK's National Health Service deploy the first mobile application that lets users self-report in chronic illness. His mission in life is to create media systems that foster wellness.

Travis Lee Street

HEAD OF WEB

Travis Lee Street joined BioBeats in May 2013. Obsessed with creative projects, health, fitness and mental wellness, Travis uses his Bachelor's in Social Science coupled with his background in the arts, graphic design, web development, and marketing to lead the company's online presence and drive user growth.

Gabriele Cocco

SOFTWARE ENGINEER

Gabriele joined Biobeats as a Designer and Software Engineer. He has a Masters and PhD from the University of Pisa and is focused on developing algorithms and languages for high-performance parallel computing. Gabriele loves speed and efficiency and is inspired by nature which has led to him collaborating with multinational chip makers and software companies like Intel, AMD and Microsoft.

Leonardo Bartoloni

CORE GPU DEVELOPER

Former physics student at "Scuola Normale" at the University of Pisa, Leonardo is now a PhD student in Computer Science. Before applying for his PhD he tried working for local companies doing OpenGL iOS work, but he couldn't find anything challenging enough. Then we found him and all that changed.

Francesco Crecchi

iOS Developer

Francesco is a Master degree student in computer science at the University of Pisa. With an entrepreneurial mind, scientific background and programming skills he is a perfect fit with the BioBeats team. He originally joined the team as an iOS Developer has since expanded his work into IT Security and UI Design. His motto is “every day leads a new opportunity - go and get it!"

Michael Sanelli

ANDROID DEVELOPER

Michael is a student of computer science at the University of Pisa, where he is specializing in the environment of computer security and has been responsible for developing graphics for various international clients. In addition, he is an expert Android application development and interaction between web-client and home automation modules.

Elise Plans

COMPOSER

Elise studied composition before training as a broadcast technician with the BBC. She worked as a technical operator with the BBC, and an engineer for Talkback Thames drama production, before returning to news with Bloomberg Television. At BioBeats, she writes adaptive music as a programmer in dataflow languages.

Our Advisors and Investors

Deepak Chopra

Scooter Braun

Will Smith

Ken Hertz

Mark Beaven

ENIAC Ventures

James Pallotta

Kevin Colleran

Stillmotion Films

Cantora Records

Zhen Fund

Justin Boreta

The Far East Movement

Sandeep Sood

Ethelbert Williams

Sam Salisbury

Our Angel Round was supported by a range of people in the American entertainment industry and the consumer health and wellness space. As we develop clinical applications for our technology and extend our global reach, our investor base is growing to reflect the evolving shape of the business.

Inquiries